Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Testicular Neoplasms 1Seminoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Necrosis 1Medulloblastoma 1Hepatoblastoma 1Hearing Loss 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 3Mitomycin 3Fluorouracil 3Leucovorin 2Doxorubicin 2Cisplatin 2surufatinib 1sodium thiosulfate 1sintilimab 1irinotecan sucrosofate 1dehydroftorafur 1Platinum 1Pafolacianine 1Mitozytrex 1Irinotecan 1Hyperthermic Intraperitoneal Chemotherapy 1DNA Fingerprinting 1Capecitabine 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Appendiceal Neoplasms × sodium thiosulfate × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡